enGene Holdings Inc.
NASDAQ: ENGN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ronald H. W. Cooper
- Employees
- 56
- Headquarters
- Saint-Laurent, Canada
- IPO year
- 2022
- Market cap
- $89.6M
- Website
- https://www.engene.com
Loading ENGN…
Loading profile data…Frequently asked questions about ENGN
What does enGene Holdings Inc. (ENGN) do?
Operating through its subsidiary, enGene, Inc., enGene Holdings Inc. functions as a clinical-stage biotechnology firm. Its core mission involves pioneering genetic pharmaceuticals, achieved by administering therapeutic agents directly to mucosal tissues and other bodily organs. A key asset in its pipeline is EG-70, also known as detalimogene vor...
Where does ENGN trade?
enGene Holdings Inc. (ENGN) trades on the NASDAQ Capital Market.
What sector is ENGN in?
enGene Holdings Inc. (ENGN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of enGene Holdings Inc.?
Ronald H. W. Cooper is the chief executive officer of enGene Holdings Inc. (ENGN).
Where is enGene Holdings Inc. headquartered?
enGene Holdings Inc. is headquartered in Canada.
Does ENGN pay a dividend?
enGene Holdings Inc. (ENGN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ENGN go public?
enGene Holdings Inc. (ENGN) completed its initial public offering in 2022.